We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




RNAi Library to Be a Public Resource

By Biotechdaily staff writers
Posted on 29 Nov 2004
A three-year project to establish an RNAi (RNA interference) library that targets genes linked to environmentally related diseases has recently been funded with a grant of U.S.$3 million.

RNAi is also known as antisense RNA. More...
The antisense approach to gene silencing involves injecting an organism with an RNA sequence complementary to messenger RNA (mRNA) transcribed from a target gene. The antisense RNA hybridizes with the sense mRNA and the double-stranded (DS) molecule blocks translation and production of an encoded protein. The presence of the dsRNA duplex led to what is now recognized as an RNA interference effect.

The work to develop the library's collection will be carried out by Icoria (Research Triangle Park, NC, USA), a biotechnology company that applies its proprietary systems biology platform to the discovery of safer, more effective drugs and agrichemicals. Once established, the library will be a resource available to the scientific community administered by the [U.S.] National Institute of Environmental Health Sciences (NIEHS) National Center for Toxicogenomics (Research Triangle Park, NC, USA).

"It is a rapid and powerful new tool to augment more traditional and time-consuming methods to accomplish our goal of verifying disease pathways,” said Dr. Kenneth Olden, director of the NIEHS. "We are very pleased to carry out this important work that will benefit the entire scientific community by making the information available to the public.”




Related Links:
Icoria
[U.S.] NIEHS Nat'l Center for Toxicogenomics

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.